总体生存期-话题@MedSci

#总体生存期#

7篇内容 | 759人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1530817, encodeId=0abc153081e77, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=Br J Cancer：RAS突变对于早发性和晚发性结直肠癌肝转移切除患者总体生存期的影响, objectType=article, longId=203813, objectId=1a49203813ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a49203813ee, replyNumber=0, likeNumber=50, createdTime=2020-11-28, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a49203813ee, moduleTitle=Br J Cancer：RAS突变对于早发性和晚发性结直肠癌肝转移切除患者总体生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a49203813ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530816, encodeId=e58f153081679, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=JCLA：甲状旁腺切除术可降低血清完整甲状旁腺激素和钙的水平，延长老年血液透析患者严重继发性甲状旁腺功能亢进的总体生存期？, objectType=article, longId=175511, objectId=1caf1e551114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1caf1e551114, replyNumber=0, likeNumber=51, createdTime=2019-07-16, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1caf1e551114, moduleTitle=JCLA：甲状旁腺切除术可降低血清完整甲状旁腺激素和钙的水平，延长老年血液透析患者严重继发性甲状旁腺功能亢进的总体生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1caf1e551114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530815, encodeId=14a715308150e, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, objectType=article, longId=101094, objectId=fe6610109450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe6610109450, replyNumber=0, likeNumber=37, createdTime=2017-06-09, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe6610109450, moduleTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6610109450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530814, encodeId=1968153081455, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=NEJM：帕妥珠单抗，曲妥珠单抗和多西他赛联合用药：提高HER2阳性转移性乳腺癌患者总体生存期, objectType=article, longId=48932, objectId=982548932ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=982548932ef, replyNumber=0, likeNumber=0, createdTime=2015-04-04, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=982548932ef, moduleTitle=NEJM：帕妥珠单抗，曲妥珠单抗和多西他赛联合用药：提高HER2阳性转移性乳腺癌患者总体生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=982548932ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530813, encodeId=0d3b1530813ba, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=APLCC 2014：阿法替尼可延长亚洲非小细胞肺癌患者总体生存期（LUX-Lung 6研究）, objectType=article, longId=42593, objectId=c717425931e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c717425931e, replyNumber=0, likeNumber=40, createdTime=2014-11-15, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c717425931e, moduleTitle=APLCC 2014：阿法替尼可延长亚洲非小细胞肺癌患者总体生存期（LUX-Lung 6研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c717425931e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530812, encodeId=892f15308127b, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=Lancet Oncol：围手术期化疗对于结直肠癌肝转移患者的总体生存期获益并无显著影响, objectType=article, longId=25619, objectId=ac5925619fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac5925619fc, replyNumber=0, likeNumber=56, createdTime=2013-10-23, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac5925619fc, moduleTitle=Lancet Oncol：围手术期化疗对于结直肠癌肝转移患者的总体生存期获益并无显著影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac5925619fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530811, encodeId=9d0c153081124, content=<a href='/topic/show?id=977f52e4425' target=_blank style='color:#2F92EE;'>#总体生存期#</a>, objectTitle=JCO：凡德他尼未能提高晚期肺癌患者的总体生存期, objectType=article, longId=4306, objectId=e19e430637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e19e430637, replyNumber=0, likeNumber=51, createdTime=2012-03-14, rootId=0, userName=swallow, userId=178512139002, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e19e430637, moduleTitle=JCO：凡德他尼未能提高晚期肺癌患者的总体生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e19e430637)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

总体生存期

2020-05-29

swallow (审核中...)

前往app查看评论内容

#总体生存期#

Br J Cancer：RAS突变对于早发性和晚发性结直肠癌肝转移切除患者总体生存期的影响

2020-11-28

swallow (审核中...)

前往app查看评论内容

#总体生存期#

JCLA：甲状旁腺切除术可降低血清完整甲状旁腺激素和钙的水平，延长老年血液透析患者严重继发性甲状旁腺功能亢进的总体生存期？

2019-07-16

swallow (审核中...)

前往app查看评论内容

#总体生存期#

SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！

2017-06-09

swallow (审核中...)

前往app查看评论内容

#总体生存期#

NEJM：帕妥珠单抗，曲妥珠单抗和多西他赛联合用药：提高HER2阳性转移性乳腺癌患者总体生存期

2015-04-04

swallow (审核中...)

前往app查看评论内容

#总体生存期#

APLCC 2014：阿法替尼可延长亚洲非小细胞肺癌患者总体生存期（LUX-Lung 6研究）

2014-11-15

仁心济世 (审核中...)

前往app查看评论内容

#总体生存期#

Lancet Oncol：围手术期化疗对于结直肠癌肝转移患者的总体生存期获益并无显著影响

2013-10-23

swallow (审核中...)

前往app查看评论内容

#总体生存期#

JCO：凡德他尼未能提高晚期肺癌患者的总体生存期

2012-03-14

科室
- - 订阅+
  - 更多科室
工具
服务